PATENT CLAIM ANALYSIS

Application Number: 15985698
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "613000"]

Abstract:
The invention provides amides that inhibit cellular necrosis and/or human receptor interacting protein 1 kinase (RIP1), including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.

Claim (Index 11):
The compound of  claim 3 , wherein R 4  is 1,1-dimethylpropyl, optionally fluorinated.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.34483
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15632412', '15632422', '15829541', '12274105', '11658533']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7155178412299831
- 35 USC 102 Novelty (BERT): 0.5276576067201354
- Combined Prediction Score: 0.6967318177789983
- Mean Citation Score: 273.25543
- Max Citation Score: 325.9432
- Similarity Product: 268.90958612036707

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test